Clinical trial at IU School of Medicine improves treatment of genetic rickets
IMAGE: Erik Imel, MD view more Credit: Indiana University School of Medicine A new study shows a drug developed in conjunction with investigators at Indiana University School of Medicine to alleviate symptoms of a rare musculoskeletal condition is significantly more effective than conventional therapies. The findings are published in Lancet. X-linked hypophosphatemia, or XLH, is a…